Patents by Inventor Francisco Xavier RUIZ

Francisco Xavier RUIZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Friction reducers for dissolved solids tolerance
    Patent number: 11920086
    Abstract: A variety of methods and compositions are disclosed, including, in one embodiment, A friction reducer comprising: a continuous phase comprising a base oil and a secondary oil, wherein the secondary oil is different than the base oil; a discontinuous phase dispersed in the continuation phase, wherein the discontinuous phase comprises water and a water-soluble polymer; and an emulsifying surfactant.
    Type: Grant
    Filed: August 31, 2022
    Date of Patent: March 5, 2024
    Assignee: Halliburton Energy Services, Inc.
    Inventors: Nicole Mast-Hale, Denise Nicole Benoit, I Wayan Rakananda Saputra, Francisco Xavier Ruiz, II
  • Friction Reducers For Dissolved Solids Tolerance
    Publication number: 20240067870
    Abstract: A variety of methods and compositions are disclosed, including, in one embodiment, A friction reducer comprising: a continuous phase comprising a base oil and a secondary oil, wherein the secondary oil is different than the base oil; a discontinuous phase dispersed in the continuation phase, wherein the discontinuous phase comprises water and a water-soluble polymer; and an emulsifying surfactant.
    Type: Application
    Filed: August 31, 2022
    Publication date: February 29, 2024
    Applicant: Halliburton Energy Services, Inc.
    Inventors: Nicole Mast, Denise Nicole Benoit, I Wayan Rakananda Saputra, Francisco Xavier Ruiz, II
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20230271926
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: May 10, 2023
    Publication date: August 31, 2023
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. McHARDY, Francisco Xavier RUIZ, Ambrosio LOPEZ, Bismarck CAMPOS, Hua-Yu Leo WANG
  • Inhibition of Olig2 activity
    Patent number: 11691951
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: July 4, 2023
    Assignee: CURTANA PHARMACEUTICALS, INC.
    Inventors: Graham Beaton, Fabio C. Tucci, Satheesh B. Ravula, Stanton F. McHardy, Francisco Xavier Ruiz, Ambrosio Lopez, Bismarck Campos, Hua-Yu Leo Wang
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20210347739
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: July 2, 2021
    Publication date: November 11, 2021
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. McHARDY, Francisco Xavier RUIZ, Ambrosio LOPEZ, Bismarck CAMPOS, Hua-Yu Leo WANG
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20210114991
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: November 20, 2020
    Publication date: April 22, 2021
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. McHARDY, Francisco Xavier RUIZ, Ambrosio LOPEZ, Bismarck CAMPOS, Hua-Yu Leo WANG
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20180244631
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: February 26, 2016
    Publication date: August 30, 2018
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. MCHARDY, Francisco Xavier RUIZ, III, Ambrosio LOPEZ, Jr., Bismarck CAMPOS, Hua-Yu Leo WANG